Shareholding disclosure

ADDEX THERAPEUTICS LTD

Declared position

31.84%

Threshold

Crossed downwards

Timeline

Published

14.04.2018

Transaction

03.04.2018

Transfer date

03.04.2018

Voting rights breakdown

Voting rights acquired7.44%

Voting rights sold31.84%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAI4B00020

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ADDEX THERAPEUTICS LTD

Addex Therapeutics Ltd14.04.2018TAI4B00020

Disclosure summary

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd on the disposal side, published by SIX Exchange Regulation on 14.04.2018, at 31.84% of voting rights. Notice category: Single shareholder.

Disclosed position

31.84%

Voting rights sold

Voting rights acquired7.44%

Voting rights sold31.84%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd, published on 14.04.2018.

Publication date14.04.2018

Transaction date03.04.2018

Transfer date03.04.2018

Issuing companyAddex Therapeutics Ltd

Beneficial ownerADDEX THERAPEUTICS LTD

Declared addressADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

CategorySingle shareholder

Voting rights acquired7.44%

Voting rights sold31.84%

Below threshold0%

ExchangeXSWX

Notification IDTAI4B00020

Commercial register

CHE-113.514.094

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 14.04.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open